T follicular helper (T FH ) cells are specialized effector CD4 + T cells that help B cells develop germinal centers and memory. However, the transcription factors that regulate T FH differentiation remain incompletely understood. Here we report that selective loss of either Lef1 (LEF-1) or Tcf7 (TCF-1) resulted in T FH defects, while deletion of Lef1 and Tcf7 severely impaired T FH differentiation and germinal centers. Forced expression of LEF-1 enhanced T FH differentiation. LEF-1 and TCF-1 coordinated T FH differentiation by two general mechanisms. First, they established the responsiveness of naïve CD4 + T cells to T FH signals. Second, they promoted early T FH differentiation via the multipronged approach of sustaining expression of IL-6Rα and gp130, enhancing ICOS expression, and promoting expression of Bcl6.
T cell help to B cells is a critical component of adaptive humoral immunity 1, 2 . During viral infections, the formation of germinal centers (GCs) by antigen (Ag)-specific B cells requires key signals provided by T follicular helper (T FH ) cells 3 , resulting in the development of high-affinity long-lived plasma cells and memory B cells 4, 5 . T FH differentiation begins outside of B cell follicles in a stepwise fashion. Early induction of key molecules of T FH differentiation, such as Bcl6, CXCR5, ICOS, and PD-1, occurs in the T cell zone when CD4 + T cells interact with Ag-presenting dendritic cells (DCs) or other antigen presenting cells (APCs), which then enable the migration of the activated CD4 + T cells towards the border of B cell follicles. Upon recognition of cognate Ag-presenting B cells, the differentiating T FH cells migrate deep inside B cell follicles and further differentiate into GC T FH cells as they direct the generation of GC B cells.
The requirement of repeated interactions with APCs is an important feature of T FH differentiation 3 , which is presumably connected to the maintenance of the activity of critical transcription factors such as Bcl6 6, 7, 8 , Batf 9 , STAT3 10, 11, 12 , STAT1 10 , and Ascl2 13 that support T FH differentiation. Among them, Bcl6 function is absolutely critical. T FH differentiation is completely abrogated in Bcl6 −/− CD4 + T cells 6, 7, 8 and ectopic Bcl6 expression in CD4 + T cells leads to augmented T FH differentiation 6, 9 . A number of signaling molecules have been identified that can regulate Bcl6 expression in CD4 + T cells 14 . However, attempts to polarize CD4 + T cells to T FH in vitro using IL-6 and IL-21 fail to reproducibly induce Bcl6 and CXCR5 expression. Therefore, there are clear gaps in our understanding of the molecular requirements for Bcl6 induction and the factors that support T FH differentiation 3 .
LEF1-1 and TCF-1 (encoded by Lef1 and Tcf7, respectively) are transcription factors that contain a conserved high mobility group (HMG) DNA binding domain. TCF-1 and LEF-1 are known for their essential roles in early T cell development, including T lineage specification and β-selection during the CD4 − CD8 − double negative stage 15, 16 . TCF-1 and LEF-1 critically regulate CD4 + versus CD8 + T cell lineage commitment upon completion of positive selection of CD4 + CD8 + double positive thymocytes 17, 18 . In mature CD8 + T cells, TCF-1 and LEF-1 regulate the generation, maturation and longevity of memory CD8 + T cells in response to viral or bacterial infection 19, 20, 21 . In mature CD4 + T cells, TCF-1 promotes T H 2 differentiation in vitro via positive regulation of GATA-3 22 . TCF-1 restrains expression of interleukin 17 (IL-17A) in developing thymocytes and activated CD4 + T cells 23 . In addition, TCF-1 can interact with the transcription factor Foxp3 and appears to oppose Foxp3-mediated gene repression in regulatory CD4 + T cells 24 .
Here we looked for undiscovered regulators of early T FH differentiation and found that LEF-1 and TCF-1 are critical transcriptional regulators of T FH differentiation. Using a knock-in reporter system and RNA-seq analysis we found that these transcription factors were highly expressed in T FH cells upon viral or bacterial infections. Genetic deletion of Lef1, Tcf7, or both factors in CD4 + T cells led to T FH differentiation defects in a dose dependent manner. As a consequence, the magnitude of B cell responses and germinal center reactions was substantially diminished in LEF-1-and TCF-1-deficient mice after infection. Mechanistically, LEF-1 and TCF-1 regulate multiple interacting mechanisms upstream of Bcl6 to preferentially instruct activated CD4 + T cells to undertake T FH differentiation.
RESULTS

Transcriptional profiles of early T FH cells versus T H 1 cells
Initial CD4 + T cell contact with APCs in the T cell zone can promote expression of key T FH molecules including Bcl6 and CXCR5. By 72 hours into an acute viral infection, the early T FH and T H 1 cells have become fate-committed 25, 26 . Early T FH cells are IL-2Rα lo Bcl6 hi Blimp1 − CXCR5 hi , while early T H 1 cells are IL-2Rα + and Tbet hi Bcl6 − Blimp1 hi in the context of acute viral and bacterial infections 25, 26, 27, 28 . To identify new factors important in the programming of T FH cells we performed gene expression analysis on early T FH and T H 1 cells using RNA-seq. Congenically marked CD45.1 + Blimp1-YFP reporter LCMV-specific TCR transgenic CD4 + T cells (SMARTA) were transferred into B6 host mice given an acute infection with the Armstrong strain of LCMV (LCMV-Arm), and early T FH and T H 1 cells were isolated three days after infection and purified to homogeneity by sorting IL-2Rα − Blimp1-YFP − and IL-2Rα + Blimp1-YFP + cells, respectively. RNA-seq was performed on the isolated RNA and early T FH and T H 1 transcriptome profiles were obtained (Fig. 1a-b) . Analysis revealed that approximately 1,200 genes were upregulated more than 1.5 fold in early T FH cells relative to T H 1 cells, and 1,600 genes were downregulated more than 1.5 fold (Fig. 1b) . Early T FH cells expressed many genes that are also preferentially expressed by fully differentiated T FH and GC T FH (Bcl6, Cxcr5, Pdcd1, Pou2af1 and Tnfsf8 among others) and had low expression of many genes repressed in fully differentiated T FH and GC T FH (Prdm1, Tbx21, IL2ra, Gzmb and Prf1 among others) (Fig. 1a, b) . Thus, major attributes of T FH and T H 1 cells are transcriptionally well defined by day 3 of an acute viral infection.
Lef1 is a transcriptional regulator of T FH differentiation
To further filter the 2,800 gene expression differences between early T FH cells and T H 1 cells, we focused on transcription factors. We then performed an additional set of RNA-seq experiments using in vitro activated CD4 + T cells under T H 1 polarizing conditions (IL-12 + αIL-4 + αTGF-β) or with IL-6 (IL-6 + αIFN-γ+αIL-12). These screening conditions were used because in vitro stimulation of CD4 + T cells in the presence of IL-6 resulted in some gene expression changes associated with T FH differentiation ( Supplementary Fig. 1a -c. Most notably, Il21 was robustly induced by IL-6); however, major aspects of T FH biology were not detected in IL-6-stimulated CD4 + T cells, such as CXCR5 protein expression and sustained Bcl6 expression 3, 13, 29, 30 ( Supplementary Fig. 1f ). This outcome suggested that key transcriptional regulators required for T FH differentiation are not induced under IL-6 conditions in vitro. We next performed a comparative analysis of gene expression differences between the in vivo generated early T FH and the in vitro IL-6 stimulated CD4 + T cells. To reveal critical unidentified early upstream transcriptional regulators of T FH differentiation we focused on genes meeting two conditions: preferential expression by early T FH cells in vivo and lack of differential expression after in vitro stimulation with IL-6. Lef1 satisfied these two conditions (Fig. 1b, Supplementary Fig. 1d, g ) and was selected for further analysis in part because LEF-1 is required for the formation of memory CD8 + T cells 20 and there are similarities between T FH and memory CD8 + T cell differentiation 25, 31 .
When expressed in SMARTA CD4 + T cells, an shRNAmir expression vector targeting Lef1 (shLef1-RV) inhibited expression of both LEF-1 protein isoforms (Fig. 1c) . To test whether early T FH differentiation in vivo is dependent on LEF-1, SMARTA CD45.1 + CD4 + T cells expressing a control shRNA (shCtrl) or shLef1 + SMARTA CD4 + T cells were transferred into B6 mice. Three days after LMCV infection of recipient mice, shLef1 + SMARTA CD4 + T cells produced approximately half the number of early T FH cells compared to shCtrl + SMARTA CD4 + T cells as assessed by flow cytometry using either Bcl6 + CXCR5 + (Fig. 1e) or IL2Rα − CXCR5 + (Fig. 1f) phenotyping. The impact of LEF-1 knock-down was selective to T FH differentiation, as SMARTA CD4 + T cell activation (CD44 upregulation, not shown) and proliferation (Fig. 1d) were comparable between shCtrl + and shLef1 + CD4 + T cells. The reduced T FH differentiation by shLef1 + CD4 + T cells indicated that LEF-1 may be an important and dose limiting contributor to this process.
Lef1 controls T FH differentiation and germinal center formation
We next examined whether LEF-1 function in CD4 + T cells was important for GC T FH differentiation and germinal center reactions. shLef1 + or shCtrl + SMARTA CD4 + T cells were transferred into B6 mice and analyzed 8 days after acute LCMV infection of the recipient mice. Activation and proliferation of CD4 + T cells were not affected by reduced Lef1 expression compared to shCtrl (Fig. 2a) , but T FH differentiation of shLef1 + cells was impaired (Fig. 2b-c) . The shLef1 + T FH defect was less severe than that observed on day 3, potentially due to the fact that sustained gene knock-down in CD4 + T cells in vivo is difficult to accomplish under conditions of rapid proliferation. We note that we have observed milder T FH differentiation defects for most shRNAmir-RVs at peak proliferation time points compared to early time points after infection, including shRNAmir against Bcl6 (data not shown). Nevertheless, shLef1 + SMARTA CD4 + T cells showed defective differentiation into GC T FH , identified here as PSGL-1 lo CXCR5 + T cells (Fig. 2d) or Bcl6 + CXCR5 + T cells (Fig. 2e ), compared to shCtrl + SMARTA CD4 + T cells. As a result, the development of GC B cells (Bcl6 + CD19 + ) was moderately impaired in the presence of shLef1 + SMARTA CD4 + T cells as compared to shCtrl + cells (Fig. 2f) . Taken together, reduction of LEF-1 expression in CD4 + T resulted in loss of T FH and GC T FH cells and a proportional loss of GC B cells during an immune response to LCMV.
Ablation of Lef1 diminishes GC T FH differentiation
We next investigated the role of LEF-1 in T FH differentiation using conditional genetargeted Lef1 fl/fl mice. Lineage-specific deletion of Lef1 in thymocytes with Cd4-Cre impairs CD4 + T cell lineage choice and diminishes CD4 + T cell output 18 . To avoid this, we used human CD2 promoter-driven Cre recombinase transgenic mice (hCD2-Cre), which achieve gene ablation in mature T cells 32 . Mice were also crossed to the Rosa26-STOP-GFP (Rosa26 GFP ) allele. As marked by GFP expression due to excision of the floxed transcription-translation STOP sequence from Rosa26 GFP allele, over 70% of splenic CD4 + T cells in hCD2-Cre Rosa26 GFP mice were GFP + , whereas less than 15% of CD4 + thymocytes were GFP + ( Supplementary Fig. 2a ). We crossed hCD2-Cre Rosa26 GFP to the Lef1 fl/fl strain to generate hCD2-Cre Rosa26 GFP Lef1 fl/fl mice (called Lef1 −/− hereafter). Both isoforms of LEF-1 were completed ablated in GFP + CD4 + T cells from Lef1 −/− mice ( Supplementary Fig. 2b ). Late deletion of LEF-1 did not detectably affect thymocyte development or cause aberrant activation of mature T cells ( Supplementary Fig. 2d , f, h, i) but reduced total thymic cellularity by approximately 15% and mature CD4 + T cells by approximately 25% (Supplementary Fig. 2e, g ). To determine the impact of LEF-1 deficiency in CD4 + T cells on T FH differentiation, we infected Lef1 −/− mice and littermate controls (hCD2-Cre − Lef1 +/fl or hCD2-Cre + Lef1 +/+ ) with vaccinia virus and assessed the presence of CD44 hi CD62L − activated GFP + CD4 + splenic T cells on day 8 post infection. The frequency of T H 1 cells (SLAM hi CXCR5 − ) were similar in Lef1 −/− mice and littermate control mice, though the absolute numbers of SLAM hi CXCR5 − T H 1 cell were modestly decreased compared to control (p = 0.51, Supplementary Fig. 3 ), consistent with a modestly reduced CD4 + T cell compartment in uninfected Lef1 −/− mice ( Supplementary Fig. 2g ). SLAM − CXCR5 + T FH cell numbers were more markedly decreased in the vaccinia virusimmunized Lef1 −/− mice compared to littermate controls (p = 0.006, Fig. 3a) . In particular, the number of GC T FH cells were diminished to a much greater extent in Lef1 −/− mice compared to littermate controls (Bcl6 + CXCR5 + and PD-1 hi CXCR5 + phenotyping Fig. 3b,c) . These data further corroborate a role of LEF-1 in directing T FH differentiation.
TCF-1 expression is retained in T FH but not T H 1 cells
RNA-seq analysis of early T FH and T H 1 cells isolated from B6 mice revealed that Tcf7 was also strongly expressed by early T FH cells, but Tcf7 was not induced by in vitro stimulation of CD4 + T cells with IL-6 (Fig. 1b, Supplementary Fig. 1e, g ). Given that LEF-1 and TCF-1 are related transcription factors, we investigated whether TCF-1 was also an early regulator of T FH differentiation. For this purpose, we generated Tcf7-GFP knock-in mice (called Tcf7 GFP here, Supplementary Fig. 4a ). The Tcf7-GFP reporter was abundantly expressed in CD4 + and CD8 + T cells and CD4 + CD25 + regulatory T cells but was absent in B220 + cells, demonstrating the reporter fidelity ( Supplementary Fig. 4b-d) . The expression of Tcf7-GFP was highest in CD44 lo CD62L + naïve T cells but was low in antigen-experienced T cell subsets such as CD44 hi CD62L + memory-phenotype T cells, and particularly CD44 hi CD62L − effector-phenotype T cells ( Supplementary Fig. 4b, c) . To analyze TCF-1 expression kinetics in antigen-specific CD4 + T cells we generated Tcf7 GFP/+ SMARTA mice and adoptively transferred naïve CD44 lo CD62L + SMARTA CD45.2 + CD4 + T cells into CD45.1 + congenic recipients. Following LCMV infection, Tcf7-GFP expression was greatly diminished in SLAM hi CXCR5 − T H 1 cells by day 8 post-infection compared to naive CD4 T cells, while Tcf7-GFP expression was maintained at a high level by most SLAM lo CXCR5 + T FH cells (Fig. 4a ).
We next investigated if the retention of TCF-1 expression was associated with the T FH differentiation program in response to other in vivo stimuli. Following adoptive transfer of Tcf7 GFP SMARTA CD4 + T cells, we infected recipient mice with Listeria monocytogenes expressing the GP61 epitope of LCMV. In other experiments, we directly infected Tcf7 GFP/+ mice with vaccinia virus, as a second viral infection model. Whereas SLAM hi CXCR5 − T H 1 cells that developed in both systems preferentially downregulated Tcf7-GFP expression, SLAM lo CXCR5 + T FH cells generated in response to both the bacterial and viral infections highly retained Tcf7-GFP expression ( Supplementary Fig. 4e, f) . Considering that TCF-1 is known to be markedly downregulated in effector CD8 + T cells 33 , these observations indicate that retention of TCF-1 expression at the effector phase of a T cell response is unique to T FH cells, and further suggest a possible requirement for TCF-1 in T FH differentiation.
Both LEF-1 and TCF-1 are essential for T FH responses
To address the role of TCF-1 in T FH cells, we generated hCD2-Cre Rosa26 GFP Tcf7 fl/fl mice (called Tcf7 −/− hereafter), where all isoforms of TCF-1 were ablated from GFP + CD4 + T cells ( Supplementary Fig. 2c ). To investigate the functional redundancy between LEF-1 and TCF-1 we also crossed Tcf7 −/− with Lef1 −/− mice to generate Lef1 −/− Tcf7 −/− mice (hCD2-Cre Rosa26 GFP Lef1 fl/fl Tcf7 fl/fl ). Similar to the Lef1 −/− mice, we did not observe T cell development defects or aberrant activation of mature T cells in Tcf7 −/− mice or Lef1 −/− Tcf7 −/− mice ( Supplementary Fig. 2 ). Although a modest reduction in thymic and splenic cellularity was observed in Tcf7 −/− mice, this was not evident in Lef1 −/− Tcf7 −/− mice compared to littermate controls (hCD2-Cre − Lef1 +/fl Tcf7 +/fl or hCD2-Cre + Lef1 +/+ Tcf7 +/+ ) ( Supplementary Fig. 2d , f, h, i). We examined the CD4 + T cell responses of the Lef1 −/− Tcf7 −/− mice in response to vaccinia virus infection. On day 8 after infection, analysis of CD44 hi CD62L − activated GFP + CD4 + T cells revealed that the frequencies and numbers of SLAM lo CXCR5 + T FH cells were diminished in Tcf7 −/− mice compared to control mice ( (Fig. 4f) . As a result, vaccinia virus-specific Ab production was significantly impaired in Lef1 −/− Tcf7 −/− mice compared to controls ( Supplementary Fig. 5 ). In summary, our data indicate that LEF-1 and TCF-1 play critical roles in T FH differentiation and, consequently, B cell help functions in a CD4 + T cell intrinsic manner.
Ectopic Lef1 expression augments T FH differentiation
We next tested whether enhanced expression of one of these transcription factors could augment T FH differentiation of antigen-specific CD4 + T cells. Given that LEF-1 and TCF-1 exhibited overlapping activities instructing T FH differentiation, we examined T FH differentiation of CD4 + T cells after ectopic expression of LEF-1. LEF-1 can be expressed as two isoforms in CD4 + T cells due to differential promoter usage (Fig. 1c) , with the fulllength isoform containing a unique N-terminal β-catenin-binding domain. We used a retrovirus expressing the full-length Lef1 (Lef1-RV + ) and confirmed increased expression of LEF-1 protein in Lef1-RV + SMARTA CD45.1 + CD4 + T cells by flow cytometry (Fig. 5a ) and immunoblot analysis (data not shown). GFP-RV + or Lef1-RV + CD45.1 + SMARTA CD4 + T cells were transferred into B6 mice, which were then infected with LCMV. The overall activation and proliferation of Lef1-RV + CD4 + T cells was normal compared to GFP-RV + CD4 + T cells ( Fig. 5b and data not shown). Ectopic LEF-1 expression resulted in enhanced T FH development by Lef1-RV + cells compared to GFP-RV + cells 8 days postinfection (Fig. 5c ). Moreover, we found that Lef1-RV + T H 1 cells (SLAM hi CXCR5 − ) exhibited unexpectedly increased expression of canonical T FH molecules CXCR5 (Fig. 5d ) and PD-1 (Fig. 5e ) compared to GFP-RV + cells. Most importantly, GC T FH cells (phenotyped as either PSGL-1 lo CXCR5 + or PD-1 hi CXCR5 + cells Fig. 5f, g ) developed at significantly higher frequencies among Lef1-RV + SMARTA CD4 + T cells compared to GFP-RV + control cells. (Fig. 6b) .
LEF-1 enhances expression of IL-6 receptors and ICOS
Considering the induction of both IL-6 receptor genes Il6rα and Il6st in Lef1-RV + T H 1 cells and the fact that IL-6 receptor signaling is one of the earliest signals that instructs T FH cell differentiation 3 , we tested whether LEF-1-augmented T FH differentiation may be mediated through enhanced surface expression of IL-6Rα and gp130 (also known as IL-6Rβ, encoded by Il6st). We analyzed the expression of IL-6Rα and gp130 on the surface of Lef1-RV + and GFP-RV + SMARTA CD4 + T cells at day 3 after infection with LCMV, a time when IL-6 receptor signaling is known to be critical for T FH differentiation 10 . Ectopic expression of LEF-1 in Lef1-RV + SMARTA CD4 + T cells resulted in increased expression of IL-6Rα compared to GFP-RV + SMARTA CD4 + T cells (Fig. 6c) . When comparing IL-6Rα expression between naïve CD4 + T cells and activated Lef1-RV + and GFP-RV + SMARTA CD4 + T cells, LEF-1 overexpression reduced the downregulation of IL-6Rα observed in activated GFP-RV + CD4 + T cells (Fig. 6c) . LEF-1 overexpression had similar effects on gp130, reducing the downregulation of gp130 observed in activated GFP-RV + CD4 + T cells (Fig. 6d) . We then examined the expression of IL-6Rα and gp130 on T FH and T H 1 subpopulations. A modest increase in IL-6Rα expression was observed on T FH cells, whereas Lef1-RV + T H 1 cells expressed >150% more IL-6Rα compared to GFP-RV + T H 1 cells (Fig. 6e) . While the expression of gp130 was only moderately increased in total Lef1-RV + SMARTA CD4 + T cells compared to GFP-RV + SMARTA CD4 + T cells (Fig. 6d) , gp130 was preferentially upregulated on Lef1-RV + T H 1 cells compared to GFP-RV + T H 1 cells (Fig. 6f) .
RNA-seq also revealed that Icos expression was upregulated on Lef1-RV + T H 1 cells compared to GFP-RV + T H 1 cells (Fig. 6b) . Because ICOS plays essential roles during both early and late stages of T FH differentiation 26 , we further examined ICOS expression. ICOS protein was increased in Lef1-RV + T cells compared to GFP-RV + cells (Fig. 6g) , and its upregulation occurred predominantly on Lef1-RV + T H 1 cells (Fig. 6h) Fig. 6 ). These results indicate that LEF-1-mediated regulation of IL-6 receptor complex and ICOS expression act upstream of Bcl6 expression early in T FH differentiation. (Fig. 7b) . Flow cytometry showed decreased expression of gp130 and ICOS protein on Lef1 −/− Tcf7 −/− CXCR5 + T FH cells compared to T FH cells from controls ( Fig. 7c  and 7d ). Although the decrease of Il6ra mRNA in Lef1 −/− Tcf7 −/− GC T FH cells did not reach statistical significance in the transcriptomic analysis, IL-6Rα protein expression was consistently reduced on Lef1 −/− Tcf7 −/− CXCR5 + T FH cells compared to T FH cells from control mice (P < 0.001, Fig. 7e ). These observations indicate essential and overlapping roles of both LEF-1 and TCF-1 in supporting IL-6 receptor and ICOS expression during T FH differentiation.
The amount of Bcl6 transcripts was diminished in PD-1 hi CXCR5 + GC T FH cells from Lef1 −/− Tcf7 −/− mice compared to those from control mice (Fig. 7b) , while the expression of Prdm1, which encodes the transcription factor Blimp1, was substantially elevated in Lef1 −/− Tcf7 −/− GC T FH cells (Fig. 7b ). Bcl6 and Blimp1 are known to have mutually antagonistic roles during differentiation of T FH cells 6 . Blimp1 directly inhibits Bcl6 expression and is a potent inhibitor of T FH differentiation 6, 28, 30 . We validated the increased expression of Prdm1 in Lef1 −/− Tcf7 −/− PD-1 hi CXCR5 + GC T FH by qPCR (Fig. 7f) . This increase was specific to GC T FH (PD-1 hi CXCR5 + ) and T FH (PD-1 lo CXCR5 + ) cells because T H 1 cells (CXCR5 − ) from both Lef1 −/− Tcf7 −/− and control mice expressed comparable levels of Prdm1 (Fig. 7f) . The transcription factor Ascl2 was shown to be important in T FH differentiation 13 . Ascl2 expression was reduced in Lef1 −/− Tcf7 −/− GC T FH cells, but the reduction was less pronounced in PD-1 lo CXCR5 + T FH cells compared to controls (Fig. 7f) . Rorc (encoding RORγt) and Il17a were virtually absent in control GC T FH cells, but these genes were expressed in Lef1 −/− Tcf7 −/− GC T FH cells (Fig. 7b) . Although Th17 gene expression is not normally observed in vaccinia virus infection, these observations are in line with the known role of TCF-1 in restraining Th17 differentiation 23 and indicate that LEF-1 and TCF-1 could suppress alternative T H cell fates during T FH differentiation, perhaps in conjunction with Bcl6, which is also known to suppress alternative cell fates 3 . Other transcriptional changes observed in Lef1 −/− Tcf7 −/− GC T FH cells compared to control GC T FH cells included the differential expression of POU family transcription factors (decreased expression of Pou2af1 and Pou6f1, and increased expression of Pou3f1 and Pou5f1) and key molecules in the Notch pathway (decreased expression of Hes5 and Psen2, and increased expression of Rbpj). The role of these factors in T FH cells remains to be investigated. Overall, these observations suggest that LEF-1 and TCF-1 contribute to regulation of many genes in activated, antigen-specific CD4 + T cells in vivo, including the positive regulation of Bcl6 and repression of Blimp1 to induce T FH differentiation.
TCF-1 binds directly to key T FH -associated gene loci
We used chromatin immunoprecipitation (ChIP) to assess if LEF-1 and TCF-1 directly regulate the differentially expressed genes identified above. Both TCF-1 and LEF-1 have a highly homologous HMG DNA binding domain which recognizes the same DNA consensus motif. Because TCF-1 ChIP reagents are of substantially higher quality than currently available LEF-1 reagents, we focused on identifying TCF-1 bound genes in T FH cells. Because most T FH cells retained TCF-1 expression similar to naïve CD4 + T cells (Fig. 4a) , we used our TCF-1 ChIP-seq data from naïve wild-type CD4 + T cells (unpublished) as a reference for selection of potential TCF-1 DNA binding sites. TCF-1 enrichment was observed at the transcription start site (TSS) of IL6st, the TSS of Bcl6, a −2.8kb region upstream of Bcl6 TSS and intron 3 of Prdm1 in naïve CD4 + T cells, but was not associated with the Il6ra and Ascl2 genes ( Supplementary Fig. 7a ). We then performed TCF-1 ChIP using wild-type and Tcf7 −/− naïve CD4 + T cells to ensure binding specificity. As a positive control, TCF-1 bound to the TSS of Axin2, a well characterized TCF-1 responsive gene 15 , in wild-type naïve CD4 + T cells, and this was completely abrogated in Tcf7 −/− naïve CD4 + T cells (Fig. 8a) . In addition, TCF-1 binding to Axin2 was enriched in T FH cells (CXCR5 + ) over T H 1 cells (CXCR5 − ) from B6 mice infected with vaccinia virus (Fig. 8a) , consistent with increased expression of TCF-1 protein in T FH cells. TCF-1 bound to the Il6st gene in wild-type naïve CD4 + T cells (Fig. 8b, right) , and this was also enriched in T FH cells (Fig.  8b) . Although TCF-1 did not bind the Il6ra gene in wild-type naïve CD4 + T cells, it was recruited to the Il6ra TSS in wild-type T FH cells (Fig. 8b, left) , suggesting TCF-1 recruitment to this site is part of the T FH differentiation program. Compared to naïve CD4 + T cells, TCF-1 did not exhibit enriched binding at Il6st or Il6ra locus in wild-type T H 1 cells, in line with diminished expression of both IL-6Rα and gp130 in T H 1 cells (Fig. 7c, e) . TCF-1 binding to the transcription start site of Icos was not detected (Supplementary Fig.  7b ) These data suggest that TCF-1 directly regulates the induction of IL-6 receptor chains to sustain IL-6 receptor complex expression by activated CD4 + T cells in vivo, allowing for T FH differentiation (Supplementary Fig. 8 ).
We next examined ChIP association between TCF-1 and key transcription factor genes for T FH differentiation. TCF-1 bound to intron 3 of the Prdm1 gene, the major regulatory site of Prdm1 expression 35 , in both naïve CD4 + T cells and CXCR5 + T FH cells (Fig. 8d) , suggesting a direct involvement of TCF-1 and its homologue LEF-1 in Blimp1 suppression in T FH cells. Given that Prdm1 is not expressed by naïve CD4 + T cells, binding of TCF-1 at this site suggests that TCF-1 may antagonize Prdm1 expression upon T cell activation. In addition, we observed specific binding of TCF-1 to the TSS of Bcl6 and an upstream regulatory region of Bcl6 in naive CD4 + T cells (Fig. 8c) and this binding pattern was maintained in T FH cells (Fig. 8c) . Robust enrichment of TCF-1 was observed in the Prdm1, Bcl6, Il6ra, and Il6st gene loci in wild-type T FH cells compared to Tcf7 −/− T FH cells (Supplementary Fig. 7b ). We did not observe enriched TCF-1 binding in the Ascl2 TSS (Fig.  8c-d) , albeit we could not exclude the possibility that Ascl2 is regulated by LEF-1 and TCF-1 through more distal regulatory regions. TCF-1 binding to the Bcl6 upstream region and Prdm1 intron was abrogated in T H 1 cells as compared to T FH (Fig. 8d) Fig. 8 ).
DISCUSSION
T FH differentiation can be initiated at an early time point during T cell activation, but the regulators of this important decision process are still being defined. Here we initiated an investigation to identify novel pathways in T FH differentiation by characterizing genes differentially expressed in early T FH in vivo but not modulated by supplementing IL-6 in vitro. We show that the pair of transcription factors LEF-1 and TCF-1 influence T FH differentiation by regulating circuits upstream of Bcl6. We found that LEF-1 and TCF-1 coordinate T FH differentiation by two general mechanisms. First, they establish the responsiveness of naïve CD4 + T cells to T FH signals by promoting expression of IL-6 receptor chains and binding to Prdm1 and Bcl6. Second, they promote early T FH differentiation of activated CD4 + T cells via multipronged activities sustaining expression of IL-6Rα and gp130, enhancing ICOS expression and promoting expression of Bcl6 while inhibiting Blimp1 expression.
IL-6 is a critical early regulator of T FH differentiation, as Il6 −/− mice fail to have any T FH cell differentiation during the DC priming phase of an acute antiviral immune response 10 . In mice whose DCs constitutively overexpress IL-6, the major phenotype observed is a dramatic increase in T FH cell and germinal centers 36 . Therefore, regulation of IL-6 receptor expression on naive CD4 + T cells and early activated CD4 + T cells is a clear mechanism by which LEF-1 and TCF-1 will influence T FH differentiation.
Bcl6 is essential for T FH differentiation, while Blimp1 is a powerful antagonist of T FH differentiation. Our observations that expression of LEF-1 results in aberrant expression of Bcl6 in T H 1 cells, Blimp1 expression is aberrantly upregulated in Lef1 −/− Tcf7 −/− GC T FH cells, and both Bcl6 and Prdm1 are directly bound TCF-1 targets indicate that LEF-1 and TCF-1 likely dually regulate both of these critical transcription factors. While we cannot rule out the possibility that the de-repression of Prdm1 results from reduced Bcl6 expression in Lef1 −/− Tcf7 −/− T FH and GC T FH cells, we speculate that LEF-1 and TCF-1 directly repress Prdm1 expression. LEF-1 and TCF-1 are known to positively and negatively regulate gene expression, depending on the interacting factors. For examples, both proteins can interact with β-catenin coactivator and TLE corepressors, and LEF-1 and TCF-1 repress Cd4 in CD8 + T cells 18 . Future analysis of molecular mechanisms by which LEF-1 and TCF-1 regulate Prdm1 and Bcl6 genes will be important, as will analysis of how LEF-1 and TCF-1 interact with other regulators of Bcl6 and Prdm1, such as STAT1, STAT3, STAT5, Foxo1, and Klf2 3, 10, 11, 28, 37, 38 . Nevertheless, our data provide proof that LEF-1 and TCF-1 regulate the balance between Bcl6 and Blimp1 expression.
ICOS expression was selectively impaired on Lef1 −/− Tcf7 −/− T FH cells, and ICOS expression was enhanced on Lef1-RV + cells. In multiple models, moderate ICOS changes have been observed to enhance T FH differentiation 38, 39, 40, 41 or function 42 . ICOS appears not to be a direct target of LEF-1 and TCF-1, though distal cis-elements were not explored. Alternatively, ICOS may be indirectly regulated by LEF-1 and TCF-1. Future studies will further elucidate LEF-1 and TCF-1 signaling axes modulating ICOS expression. Overall, the combined influence of LEF-1 and TCF-1 on IL-6Rα, gp130, Bcl6, Blimp1, and ICOS makes a dense network of interactions that create a strong pro-T FH signaling environment in a cell sustaining LEF-1 and/or TCF-1 expression.
LEF-1 and TCF-1 functions likely continue to be important in fully differentiated T FH and GC T FH cells. LEF-1 and TCF-1 both continue to be expressed in GC T FH cells. Bcl6 expression is essential in GC T FH cells 3 and continued regulation of both Bcl6 and Prdm1
are central aspects of GC T FH biology. ICOS is also a major regulator of GC T FH biology 26, 40 . IL-6 receptor signaling is not usually essential in GC T FH cells due to compensatory capabilities of IL-21 or IL-27 at later time points 29, 43, 44 . Nevertheless, IL-6 receptor likely plays a major role in sustaining GC T FH under normal physiological conditions. IL-6 is required for sustaining T FH and GC responses in chronic LCMV infection in mice 45 , and IL-6 is positively associated with T FH cells and GCs in SIV + macaques 46 .
The activities of LEF-1 and TCF-1 appear to pre-program the responsiveness of a given naive CD4 + T cell to T FH signals, prior to any exposure of the cell to antigen. Therefore, we speculate that transient or sustained inflammatory or pathogenic conditions that alter LEF-1 or TCF-1 expression in naive T cells may have a global impact altering the capacity of naive CD4 + T cells to respond to T FH induction signals in the presence of pathogens or autoimmunity triggers. Ultimately, it will be useful to determine how homeostatic signals act in concert with LEF-1 and TCF-1 to modulate the expression or poised status of T FHassociated genes in naïve CD4 + T cells to properly orchestrate the development progression from naive cell to T FH or non-T FH cell fates.
LEF-1 and TCF-1 are highly expressed in resting naive CD4 + and CD8 + T cells, but TCF-1 and LEF-1 are downregulated in effector CD8 + T cells and T H 1 cells, suggesting Lef1 and Tcf7 are regulated by T cell activation. TCR dwell time influences T FH versus non-T FH differentiation in a TCR signal strength intrinsic manner 47 . We speculate these processes may be interrelated.
In conclusion, our study discovers novel roles for LEF-1 and TCF-1 in T FH differentiation. Thus, a better understanding of the signals regulating LEF-1 and TCF-1 and their downstream targets in activated CD4 + T cells will have implications for understanding how to enhance T FH differentiation, as well as for understanding non-T FH CD4 + T cell differentiation processes.
METHODS
Mice and viral infections
C57BL/6J (B6), B6.SJL, Cd4-Cre, and Rosa26 GFP mice were purchased from the Jackson Laboratory. Mouse strains described below were obtained from in-house breeders of either LJI or University of Iowa animal facility. SMARTA (LCMV gp66-77-IA b specific) TCR transgenic mice 48 , Tcf7 fl/fl and Lef1 fl/fl mice were described 16, 18 . Bcl6 fl/fl mice and hCD2-Cre mice were from Drs. Toshitada Takemori 49 and Paul Love 32 , respectively. Blimp1-YFP BAC transgenic mice were crossed to the SMARTA strain to generate Blimp1-YFP SMARTA mice 26 . Tcf7-GFP reporter mice were generated in house, and detailed targeting strategy and characterization will be published elsewhere (manuscript in review). All animals were analyzed at 6-12 weeks of age, and both genders included without randomization or "blinding". All mouse experiments were performed under protocols approved by the Institutional Animal Use and Care Committees of LJI and the University of Iowa. For acute viral infection, 2.5 -5.0 × 10 5 plaque-forming units (PFU) and 2.5 × 10 5 PFU was used for LCMV Armstrong (LCMV-Arm) and vaccinia virus, respectively. Virus was prepared in plain DMEM and injected intraperitoneally or intravenously.
Flow cytometry
Single cell suspension was prepared from the spleen of mice infected with LCMV or vaccinia virus, and surface-stained as previously described 16, 26 . The fluorochromeconjugated antibodies and their clone numbers are CD4 (RM4-5), CD44 (IM7), CD62L (MEL-14), PD-1 (J43), IL-6Rα (D7715A7), gp130 (KGP130), ICOS (C398.4A), Fas (15A7), GL7 (GL7), IgD (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) , CD138 (281-2), Bcl6 (K112-91), and all were from eBiosciences. SLAM (TC15-12F12.2) was from BioLegend. PSGL-1 (2PH1) was from BD Biosciences. For detection of CXCR5, a two-step 26 or three-step 6 staining protocol was used with biotinylated anti-CXCR5 or unconjugated anti-CXCR5 Abs, respectively (2G8 from BD Biosciences). For intracellular detection of Bcl6, the surface-stained cells were fixed and permeabilized with the Foxp3/transcription factor staining buffer (eBiosciences), followed by incubation with fluorochrome-conjugated Bcl6 antibody. Data were collected on LSRII and FACSVerse (BD Biosciences) and analyzed with FlowJo software (TreeStar).
Immunoblot
For analysis of knockdown of LEF-1 or targeted deletion of TCF-1 and LEF-1, shCtrl and shLef1 SMARTA cells or CD4 + and CD8 + T cells (5 × 10 5 each) were sorted, and denatured in SDS Loading Buffer at 100°C for 5 minutes. Cell lysates were probed with anti-TCF-1 (C46C7; Cell Signaling Technology), anti-LEF-1 (C18A7 and C12A5; Cell Signaling Technology) or anti-β-actin (loading control; I-19; Santa Cruz Biotechnology).
Retroviral transductions
Naïve SMARTA CD4 + T cells were purified by negative selection using either magnetic beads (Miltenyi Biotec) or EasySep kit (STEMCELL), and resuspended in D-10 [DMEM + 10% FCS (fetal calf serum) + 2 mM GlutaMax (Life Technologies) + 100 U/ml Penicillin/ Streptomycin (Life Technologies) + 50 µM β-mercaptoethanol] with 2 ng/ml hIL-7 or 10 ng/ml hIL-2 (Peprotech). 2 × 10 6 SMARTA cells were seeded in 24-well plates coated with 8 µg/ml anti-CD3 (clone 17A2, BioXcell) and anti-CD28 (clone 37.51, BioXcell). Retroviral soups were given at 24 and 36 hours after stimulation. After 72 hours in vitro stimulation, SMARTA cells were transferred into 6-well plates in D-10 with 10 ng/ml hIL-2 for two days. One day prior to cell sorting reporter expressing cells (FACSAria, BD Biosciences) for transfer, culture media was replaced with D-10 with 2 ng/ml hIL-7. Detailed information is described elsewhere 50 .
Cell sorting
All the cell sorting was done on a FACSAria (BD Biosciences). 
Retrovirus production and cell transfers
Murine Lef1 cDNA (clone ID 6401514, Open Biosystems) was cloned into expressing retroviral vector (pMIG-GFP). Lef1 shRNA sequence (Transomic) was cloned into pLMPdAmetrine vector, as reported 26, 31 . Virions were obtained from the Plat-E cells as described 50 . Briefly, culture supernatants were collected 24 and 48 hours after transfection, filtered through 0.45 µm syringe filter, and saved at 4°C until used for transductions.
Naïve or retrovirally transduced SMARTA cells were transferred into mice intravenously via retro-orbital sinus. When using transduced SMARTA cells, 100% of transferred cells were transduced (Ametrine + CD45.1 + ). Cell transfer numbers are 4-5 × 10 5 , 2 × 10 5 , and 5 × 10 3 SMARTA cells were day 3, 4, and 8 experiments, respectively.
In vitro activation of CD4 + T cells
Naïve SMARTA cells were negatively isolated by using CD4 + T cell isolation kit (Miltenyi or StemCell). 2 × 10 6 SMARTA cells were seeded on 24 well plates coated with 8 µg/mL αCD3 (clone 17A2, BioXcell) and αCD28 (clone 37.51, BioXcell). For T H 1polarization, Smarta cells were given with 20 µg/mL of αIL-4 (clone 11B11, BioXcell) and αTGF-β (clone 1D11, BioXcell) and 20 ng/mL of rmIL-12 (Peprotech). For IL-6 condition, 10 µg/mL of αIFN-γ (clone XMG1.2, BioXcell) and αIL-12 (clone R1-5D9, BioXcell) and 20 ng/mL of rmIL-6 (Peprotech) were added in culture media.
Quantitative RT-PCR
Total RNA from the sorted cells was extracted, reverse-transcribed, and quantitative PCR were performed as described 16 .
RNA-Seq and transcriptome analysis (Xue Group)
Total RNA was extracted from the sorted PD-1 + CXCR5 + cells from Tcf7 −/− Lef1 −/− or control mice, and two biological replicates were obtained for each genotype. cDNA synthesis and amplification were performed using SMARTer Ultra Low Input RNA Kit (Clontech) starting with 10 ng of total RNA per sample following manufacturer's instructions. cDNA was fragmented with Q800R sonicator (Qsonica) and used as input for NEBNext Ultra DNA Library Preparation Kit (NEB). Libraries were sequenced on Illumina's HiSeq2000 in single read mode with the read length of 50 nucleotides producing 60-70 million reads per sample. Sequence data in fastq format were generated using CASAVA 1.8.2 processing pipeline from Illumina. 
RNA-Seq and transcriptome analysis (Crotty Group)
Total RNA was extracted from cells stored in Trizol using the miRNeasy Mini Kit (Qiagen 217004). [1] For RNA-seq analysis for early T FH and T H 1 cells: poly(A) RNA was isolated using the Poly(A) Purist MAG kit (Ambion AM1922) from 200 ng total RNA of each sample. Resulting poly(A) RNA was then fragmented and prepared, according to the manufacturer's instructions (ABI 4452437 Rev B), into barcoded, strand-specific libraries using The SOLiD Total RNA-Seq Kit (ABI 4445374). Following library preparation, 15 ng of each library was converted into SOLiD Wildfire compatible fragments using the 5500 W Conversion Primer Kit (Life Technologies) and 5 rounds of PCR. Libraries were then pooled at equimolar concentrations using Quant-iT PicoGreen dsDNA Assay Kit (Life Technologies) and sequenced on a Life Technologies 5500XL W Genetic Analyzer. SOLiD 5500-2 sequencing outcomes were converted from color space to nucleotide space by using Galaxy solid2fastq script. [2] For RNA-seq analysis for GFP-RV + or Lef1-RV + SMARTA cells obtained 4 days after LCMV infection: 500 ng of each sample's total RNA was then prepared into mRNA libraries, according to manufacturer's instructions (Illumina, RS-122-2103). The resulting libraries were deep sequenced on the Illumina 2500 in Rapid Run Mode, using single-end reads with lengths of 50 nucleotides (> 24 million reads per condition). The single-end reads that passed Illumina filters were filtered for reads aligning to tRNA, rRNA, adapter sequences, and spike-in controls.
The reads were then aligned to UCSC mm9 reference genome using TopHat (v 1.4.1). DUST scores were calculated with PRINSEQ Lite (v 0.20.3) and low-complexity reads (DUST > 4) were removed from the BAM files. The alignment results were parsed via the SAMtools to generate SAM files. Read counts to each genomic feature were obtained with the htseq-count program (v 0.6.0) using the "union" option. After removing absent features (zero counts in all samples), the raw counts were then imported to R/Bioconductor package DESeq2 to identify differentially expressed genes among samples. DESeq2 normalizes counts by dividing each column of the count table (samples) by the size factor of this column. The size factor is calculated by dividing the samples by geometric means of the genes. This brings the count values to a common scale suitable for comparison. P-values for differential expression are calculated using binomial test for differences between the base means of two conditions. These p-values are then adjusted for multiple test correction using Benjamini Hochberg algorithm to control the false discovery rate. We considered genes differentially expressed between two groups of samples when the DESeq2 analysis resulted in an adjusted P-value of <0.05 and the fold-change in gene expression was 1.5-fold. Cluster analyses including principal component analysis (PCA) and hierarchical clustering were performed using standard algorithms and metrics. Hierarchical clustering was performed using complete linkage with Euclidean metric. RNA-seq data are deposited at the Gene Expression Omnibus under accession number GSE67336.
Heatmaps
Heatmaps were generated with normalized data of RNA-seq analyses for early T FH /T H 1 cells and for GFP-RV + /Lef1-RV + T FH /T H 1 cells. Microarray analysis used published T H 1, T FH and GC T FH cell sets (GSE21380, ref. 51 ) using the GenePattern software suite (genepattern.broadinstitute.org).
GSEA analysis
GSEA analysis was performed using the GSEA software from the Broad Institute. T FH and GC T FH gene sets were generated in-house with genes that were expressed in T FH (PD1 lo CXCR5 + ) and GC T FH (PD1 hi CXCR5 + ) by more than 2-fold in comparison to T H 1 (PD1 − CXCR5 − ) cells, respectively (data obtained from GSE21380). Enrichment of genes, which were upregulated in Lef1-RV + Th1 cells in comparison to GFP-RV + T H 1 cells by more than 1.2-fold, was then ranked by the Diff_of_Classes.
Chromatin immunoprecipitation (ChIP)
Sorted CD4 + T cells were cross-linked with 1% formaldehyde in medium for 5 minutes, processed using truChIP Chromatin Shearing Reagent Kit (Covaris), and sonicated for 5 minutes on Covaris S2 ultrasonicator. The sheared chromatin was immunoprecipitated with anti-TCF-1 (C46C7, Cell Signaling Technologies) or control rabbit IgG and washed as previously described. The immunoprecipitated DNA segments were used for PCR quantification. For calculation of enriched TCF-1 binding in a given cell type, each TCF-1 ChIP sample was first normalized to corresponding IgG ChIP sample, and the signal at a target region was then normalized to that at the Hprt promoter region.
Statistical analysis
Data sets were analyzed with the Student's t-test with a two-tailed distribution assuming equal sample variance. Data are a composite of three independent experiments (n = 10-14 per group). * P < 0.05, ** P < 0.01, *** P < 0.001 (Student's t-test) . 
